When one person orders, receives, and reconciles investigational product, a critical control disappears. See how role separation can strengthen drug accountability.
- Clinical Trial Supply Chains Are Moving From Planning For Stability To Preparing For Uncertainty
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- The Silent Stockout: No One Owns The Data That Would Have Caught It
- Token Costs Will Decide Clinical Supply AI
- What Is "Demand" When There Are No Sales?
- The Reliance Trap: When Regulatory Strategy Becomes A Clinical Supply Problem
- Clinical Trial Supply Chains Are Entering The Era Of Predictive Risk Management
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Mid-Study RTSM Migration: How To Switch Vendors Without Disrupting Your Trial
Evaluate the risks of staying with an underperforming RTSM provider versus the benefits of a mid-study transition. Modern migration tools now offer a secure path to protect trial data and timelines.
-
The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And Solutions
Explore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.
-
Choosing RTSM? Evaluate The Team Running It, Not Just The Software
High-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.
-
Managing Complex Global Drug Distribution And Expiry
A global top-ten pharma company sponsored a complex, 8-year Phase III trial across 43 countries. As costs mounted and supplies waned, it realized the trial could be better managed if outsourced.
-
What Is Interactive Response Technology (IRT)?
Learn how protocol-driven IRT systems support supply management and randomization to help trial teams cut risk and costs.
-
Building Clinical Supply Agility In A Changing Trial Landscape
Rising trial complexity demands agile supply built on integrated operations, solid planning, and fast issue resolution. Lean teams gain from partners providing flexibility, control, and global reach.
-
How Life Sciences Leaders Are Preparing For More Curveballs In 2026
Anticipate regulatory shifts and supply chain hurdles with agile scenario planning. Move beyond fragmented systems to build a resilient, data-driven foundation for a volatile industry landscape.
-
The Critical Role Of Clinical Trial Packaging Services In Trial Success
Compliant, accurate packaging protects product integrity, supports dosing consistency, and keeps studies running smoothly. Smart components and controlled processes lower risk across complex trials.
-
3 Study Areas Where Your IRT Vendor Should Do More
Find out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
- Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.